Targeting Infectious Agents as a Therapeutic Strategy in Alzheimer’s Disease Tamàs FülöpUsma MunawaraEric Frost Current Opinion 26 May 2020 Pages: 673 - 695
Potential of Glial Cell Modulators in the Management of Substance Use Disorders Jermaine D. Jones Leading Article 04 April 2020 Pages: 697 - 722
Management of Sleep Disturbances Associated with Smith-Magenis Syndrome Kevin A. KaplanSarah H. ElseaLorraine Potocki Therapy in Practice 03 June 2020 Pages: 723 - 730
Associations of Prescribed ADHD Medication in Pregnancy with Pregnancy-Related and Offspring Outcomes: A Systematic Review Lin LiAyesha C. SujanHenrik Larsson SYSTEMATIC REVIEW 24 April 2020 Pages: 731 - 747
Pharmacotherapeutic Options for Managing Pain in Multiple Sclerosis Giulia Di StefanoGianfranco De StefanoAndrea Truini Review Article 08 May 2020 Pages: 749 - 761
β-Adrenoceptor Drugs and Parkinson’s Disease: A Nationwide Nested Case–Control Study Sibylle de GermayCécile ConteMaryse Lapeyre-Mestre Original Research Article 04 June 2020 Pages: 763 - 772
Solriamfetol for the Treatment of Excessive Daytime Sleepiness in Participants with Narcolepsy with and without Cataplexy: Subgroup Analysis of Efficacy and Safety Data by Cataplexy Status in a Randomized Controlled Trial Yves DauvilliersColin ShapiroMichael J. Thorpy Original Research Article 25 June 2020 Pages: 773 - 784